Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Operating Expenses (2018 - 2025)

Historic Operating Expenses for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $947318.0.

  • Regenerative Medical Technology's Operating Expenses rose 3023.11% to $947318.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 1767.91%. This contributed to the annual value of $2.7 million for FY2024, which is 1468.25% up from last year.
  • According to the latest figures from Q3 2025, Regenerative Medical Technology's Operating Expenses is $947318.0, which was up 3023.11% from $835918.0 recorded in Q2 2025.
  • In the past 5 years, Regenerative Medical Technology's Operating Expenses ranged from a high of $9.1 million in Q3 2021 and a low of $142732.0 during Q1 2021
  • Its 5-year average for Operating Expenses is $1.2 million, with a median of $648654.0 in 2022.
  • As far as peak fluctuations go, Regenerative Medical Technology's Operating Expenses soared by 1790274.04% in 2021, and later tumbled by 9530.82% in 2022.
  • Quarter analysis of 5 years shows Regenerative Medical Technology's Operating Expenses stood at $576618.0 in 2021, then surged by 388.36% to $2.8 million in 2022, then tumbled by 79.76% to $569861.0 in 2023, then increased by 5.21% to $599565.0 in 2024, then skyrocketed by 58.0% to $947318.0 in 2025.
  • Its last three reported values are $947318.0 in Q3 2025, $835918.0 for Q2 2025, and $808934.0 during Q1 2025.